Stay updated on Exemestane in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Exemestane in NSCLC Clinical Trial page.

Latest updates to the Exemestane in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior funding-status notice while preserving existing trial content; no trial details are changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide funding/status notice was added, noting potential delays and that the NIH Clinical Center is open. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display option and updated page metadata, including the label 'Last Update Submitted that Met QC Criteria' and capitalization changes to 'No FEAR Act Data'. The revision tag was updated to v3.4.0 from v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section listing Minnesota study sites. Updated the page revision to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Exemestane in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exemestane in NSCLC Clinical Trial page.